Regentis Biomaterials Ltd., a regenerative medicine company, develops tissue repair solutions that restore the health and enhance quality of life of patients.
$1.27+6.72%
报价 2026-11-09
市值
$8.9M
EV
–
PE (TTM)
–
预期 PE
–
52 周区间距高点 -86.5%
$1.17$9.40
筛选结果
pipeline · 2026-11-09Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| RGNTRegentis Biomaterials Ltd. | $8.9M | +6.7% | – | – | – | – | – | |
| HBIOHarvard Bioscience, Inc. | $41.4M | +8.7% | +3.1% | 53% | – | 11.2x | – | |
| NEPHNephros, Inc. | $32.6M | +7.5% | +11.4% | 61.1% | 27.6x | 22.4x | – | |
| ZJYLJin Medical International Ltd. | $30.9M | +17.6% | – | 30.6% | 27.0x | 59.2x | – | |
| MLSSMilestone Scientific Inc. | $27.4M | +1.0% | +7.6% | 69.6% | – | – | – | |
| RVPRetractable Technologies, Inc. | $16.8M | -1.0% | – | – | – | – | – | |
| FEMYFemasys Inc. | $11.9M | +3.6% | +52.0% | 52.2% | – | – | – | |
| LUCYLucyd, Inc | $7.3M | +1.2% | +148.3% | 22.8% | – | – | – | |
| WOKWORK Medical Technology Group Ltd. | $3M | +32.2% | – | 12.3% | – | – | – | |
| 同行中位数 | – | – | +11.4% | 52.2% | 27.3x | 22.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
电话会纪要摘要
暂无纪要摘要。